Reviews Alcaftadine Ophthalmic Solution


No reviews yet.

Lastacaft Drug Description
LASTACAFT™
(alcaftadine) Ophthalmic Solution
DRUG DESCRIPTION
LASTACAFT™ is a sterile, topically administered H1 receptor antagonist containing alcaftadine for ophthalmic use.
Alcaftadine is a white to yellow powder with an empirical formula of C19H21N3O and a molecular weight of 307.39.
Contains:
Active: alcaftadine 0.25% (2.5 mg/mL) Preservative: benzalkonium chloride 0.005%
Inactives: edetate disodium, monobasic sodium phosphate, purified water, sodium chloride, sodium hydroxide and/or hydrochloric acid (to adjust pH)
Chemical Name: 6,11-dihydro-11-(1-methyl-4-piperidinylidene)-5#-imidazo[2,1-b] [3] benzazepine-3-carboxaldehyde
Structural Formula:







The drug product has a pH of approximately 7 and an osmolality of approximately 290 mOsm/kg.
Last reviewed on RxList: 8/20/2010




Lastacaft Drug Description
LASTACAFT™
(alcaftadine) Ophthalmic Solution
DRUG DESCRIPTION
LASTACAFT™ is a sterile, topically administered H1 receptor antagonist containing alcaftadine for ophthalmic use.
Alcaftadine is a white to yellow powder with an empirical formula of C19H21N3O and a molecular weight of 307.39.
Contains:
Active: alcaftadine 0.25% (2.5 mg/mL) Preservative: benzalkonium chloride 0.005%
Inactives: edetate disodium, monobasic sodium phosphate, purified water, sodium chloride, sodium hydroxide and/or hydrochloric acid (to adjust pH)
Chemical Name: 6,11-dihydro-11-(1-methyl-4-piperidinylidene)-5#-imidazo[2,1-b] [3] benzazepine-3-carboxaldehyde
Structural Formula:







The drug product has a pH of approximately 7 and an osmolality of approximately 290 mOsm/kg.
Last reviewed on RxList: 8/20/2010




Lastacaft Drug Description
LASTACAFT™
(alcaftadine) Ophthalmic Solution
DRUG DESCRIPTION
LASTACAFT™ is a sterile, topically administered H1 receptor antagonist containing alcaftadine for ophthalmic use.
Alcaftadine is a white to yellow powder with an empirical formula of C19H21N3O and a molecular weight of 307.39.
Contains:
Active: alcaftadine 0.25% (2.5 mg/mL) Preservative: benzalkonium chloride 0.005%
Inactives: edetate disodium, monobasic sodium phosphate, purified water, sodium chloride, sodium hydroxide and/or hydrochloric acid (to adjust pH)
Chemical Name: 6,11-dihydro-11-(1-methyl-4-piperidinylidene)-5#-imidazo[2,1-b] [3] benzazepine-3-carboxaldehyde
Structural Formula:







The drug product has a pH of approximately 7 and an osmolality of approximately 290 mOsm/kg.
Last reviewed on RxList: 8/20/2010




Lastacaft Drug Description
LASTACAFT™
(alcaftadine) Ophthalmic Solution
DRUG DESCRIPTION
LASTACAFT™ is a sterile, topically administered H1 receptor antagonist containing alcaftadine for ophthalmic use.
Alcaftadine is a white to yellow powder with an empirical formula of C19H21N3O and a molecular weight of 307.39.
Contains:
Active: alcaftadine 0.25% (2.5 mg/mL) Preservative: benzalkonium chloride 0.005%
Inactives: edetate disodium, monobasic sodium phosphate, purified water, sodium chloride, sodium hydroxide and/or hydrochloric acid (to adjust pH)
Chemical Name: 6,11-dihydro-11-(1-methyl-4-piperidinylidene)-5#-imidazo[2,1-b] [3] benzazepine-3-carboxaldehyde
Structural Formula:







The drug product has a pH of approximately 7 and an osmolality of approximately 290 mOsm/kg.
Last reviewed on RxList: 8/20/2010




Lastacaft Drug Description
LASTACAFT™
(alcaftadine) Ophthalmic Solution
DRUG DESCRIPTION
LASTACAFT™ is a sterile, topically administered H1 receptor antagonist containing alcaftadine for ophthalmic use.
Alcaftadine is a white to yellow powder with an empirical formula of C19H21N3O and a molecular weight of 307.39.
Contains:
Active: alcaftadine 0.25% (2.5 mg/mL) Preservative: benzalkonium chloride 0.005%
Inactives: edetate disodium, monobasic sodium phosphate, purified water, sodium chloride, sodium hydroxide and/or hydrochloric acid (to adjust pH)
Chemical Name: 6,11-dihydro-11-(1-methyl-4-piperidinylidene)-5#-imidazo[2,1-b] [3] benzazepine-3-carboxaldehyde
Structural Formula:







The drug product has a pH of approximately 7 and an osmolality of approximately 290 mOsm/kg.
Last reviewed on RxList: 8/20/2010





Other reviews about Alcaftadine Ophthalmic Solution on web:

Lastacaft (alcaftadine ophthalmic solution) is used for the prevention of itching associated with allergic conjunctivitis. Includes Lastacaft side effects, interactions and ... FDA Approves Lastacaft (alcaftadine ophthalmic solution) for ...


Learn about the prescription medication Lastacaft (Alcaftadine Ophthalmic Solution), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Lastacaft (Alcaftadine Ophthalmic Solution) Drug Information: Uses ...


PRINCIPAL DISPLAY PANEL - 3 mL Bottle Carton. NDC 68669-412-03. LASTACAFT ™ (alcaftadine ophthalmic solution) 0.25%. 3 mL. Sterile. VISTAKON ® PHARMACEUTICALS, LLC DailyMed: About DailyMed


Lastacaft (alcaftadine ophthalmic solution) is a topical H1 histamine receptor antagonist indicated for the ... Tribenzor Tribenzor (amlodipine, hydrochlorothiazide and olmesartan ... Diclofenac Ophthalmic Solution Side Effects | Drugs.com


LASTACAFT TM (alcaftadine ophthalmic solution) Initial U.S. Approval: 2010----- INDICATIONS AND USAGE-----LASTACAFT TM is a H 1 histamine receptor antagonist indicated for ... Lastacaft (alcaftadine) Ohthalmic Solution, Vistakon ...


Alcaftadine Approved for Allergic Conjunctivitis. Kate Traynor. BETHESDA, MD 02 August 2010—FDA on July 28 approved the labeling for alcaftadine ophthalmic solution for use in ... News Article : Alcaftadine Approved for Allergic Conjunctivitis


Alcaftadine Ophthalmic Solutions . Ophthalmic solutions containing alcaftadine were prepared in accordance with Table I. To assure sterility, the solutions were passed through 0.22 ... OCULAR ALLERGY TREATMENTS - Patent Application 20080051385


According to a release announcing the approval, Lastacaft (alcaftadine ophthalmic solution, 0.25%) will be marketed by Vistakon Pharmaceuticals in 5-mL bottles containing 3 ... Vistakon receives approval to market treatment for ocular itching


8/2010: Lastacaft™(alcaftadine) – New drug approval The FDA approved Vistakon Pharmaceuticals’ Lastacaft (alcaftadine) ophthalmic solution for the prevention of itching ... RxNews® - Drug Approvals


Lastacaft (Alcaftadine Ophthalmic Solution) drug description - FDA approved labeling for prescription drugs and medications at RxList. Vicodin (Hydrocodone Bitartrate and ... PSYCHODAL





Featured Reviews

Reviews Mefoxin

Mefoxin Drug Description MEFOXIN® (cefoxitin) Injection To reduce the development of drug-resistant bacteria and maintain the effectiveness of MEFOXIN* and other antibacterial drugs, MEFOXIN should be used only to treat or prevent infections...
Read More  |  Review This
Reviews Clarinex-D 12hr

Clarinex-D 12hr Drug Description CLARINEX-D® 12 HOUR (desloratadine 2.5 mg and pseudoephedrine sulfate, USP 120 mg) Extended Release Tablets DRUG DESCRIPTION What are the possible side effects of desloratadine and pseudoephedrine...
Read More  |  Review This
Reviews Multiple Electrolytes Inj

Plasma-Lyte 148 Drug Description PLASMA-LYTE 148 and 5% Dextrose Injection (multiple electrolytes and dextrose) Injection, Type 1, USP in AVIVA Plastic Container DRUG DESCRIPTION PLASMA-LYTE 148 and 5% Dextrose Injection (Multiple Electrolytes...
Read More  |  Review This
Reviews Pramlintide Acetate Injection

Symlin Drug Description SYMLIN® (pramlintide acetate) Injection WARNING SYMLIN is used with insulin and has been associated with an increased risk of insulin-induced severe hypoglycemia, particularly in patients with type 1 diabetes....
Read More  |  Review This
Reviews Influenza Virus Vaccine

Fluvirin Drug Description FLUVIRIN® (influenza virus vaccine) Purified Surface Antigen Vaccine 2007-2008 FORMULA DRUG DESCRIPTION What are the possible side effects of influenza virus injectable vaccine? Influenza virus...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....